In addition, patients with cryopyrin-associated periodic syndrome (CAPS) carrying a NLRP3 variant with a lowered activation threshold do not develop colonic symptoms indicative of IBD [31,32,33]. This evidence concerns the gene NLRP3 and inflammatory bowel disease.